Diagnostic Kits/SACGHS U.S. System of Oversight of Genetic Testing: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
(New page: Report of the Secretary’s Advisory Committee on Genetics, Health, and Society, U.S. System of Oversight of Genetic Testing: A Response to the Charge of the Secretary of Health and Human ...)
 
No edit summary
Line 1: Line 1:
Report of the Secretary’s Advisory Committee on Genetics, Health, and Society, U.S. System of Oversight of Genetic Testing: A Response to the Charge of the Secretary of Health and Human Services, April 2008. Available at: http://oba.od.nih.gov/oba/SACGHS/reports/SACGHS_oversight_report.pdf [Accessed July 8, 2009].
Report of the Secretary’s Advisory Committee on Genetics, Health, and Society, U.S. System of Oversight of Genetic Testing: A Response to the Charge of the Secretary of Health and Human Services, April 2008. Available at: http://oba.od.nih.gov/oba/SACGHS/reports/SACGHS_oversight_report.pdf [Accessed July 8, 2009].
'''Map of US Oversight for Genetic Testing'''
{|
| [[Image:US System of Oversight of Genetic Testing p242 C-4 Research and Development - 2008 SAGCHS.png|thumbnail|The report points out that at "(G1) there is a need for reference materials for assay, analyte, and platform validation to establish that new tests are accurate."]]
| [[Image:US System of Oversight of Genetic Testing p247 - 2008 SAGCHS.png|thumbnail|This image presents a map of the US regulatory process for diagnositics and implicitly demonstrates the diagnostic development pipeline.]]
|}

Revision as of 10:24, 2 October 2009

Report of the Secretary’s Advisory Committee on Genetics, Health, and Society, U.S. System of Oversight of Genetic Testing: A Response to the Charge of the Secretary of Health and Human Services, April 2008. Available at: http://oba.od.nih.gov/oba/SACGHS/reports/SACGHS_oversight_report.pdf [Accessed July 8, 2009].


Map of US Oversight for Genetic Testing

The report points out that at "(G1) there is a need for reference materials for assay, analyte, and platform validation to establish that new tests are accurate."
This image presents a map of the US regulatory process for diagnositics and implicitly demonstrates the diagnostic development pipeline.